הודעה על תהליך מינוי מנכ"ל חדש עד לתאריך 23 בדצמבר 2019
false
אנלייבקס תרפיוטיקס בע"מ
2
380
ENLIVEX THERAPEUTICS LTD
Corporation no:
514716489
12569
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
01/10/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-100234
Time of broadcast:
21:23
21:17:10
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
הודעה על תהליך מינוי מנכ"ל חדש עד לתאריך 23 בדצמבר 2019
29092019_6k_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
06/08/2019
Address:
Einstein
14
,
NES-ZIONA
7403618
,
ISRAEL
Tel:
02-6708072
,
Fax:
02-6708070
E-mail address:
shachar@enlivexpharm.com
Company site:
www.enlivex.com
Previous names of reporting entity:
Name of the Signatory:
SHMUEL HESS
Position of Signatory in the reporting corporation:
Chairman Of The Board
Name of Employer Company:
Enlivex thetraputics R&D
Address:
Nachal Dan
16
,
Qiryat Uno
61580
Telephone:
054-4617610
Facsimile:
-
E-mail:
shachar@enlivexpharm.com
2
ISRAEL